Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant

Research Institute of the McGill University Health Centre

$100,000.00

Regulation of TGF-beta action in chondrocytes: signaling via ALK1 versus ALK5 pathways

FY 2015-16

Summary
Arthritis commonly refers to several related conditions that affect joints, causing pain, inflammation and swelling and osteoarthritis is the most prevalent form. Osteoarthritis occurs when there is damage in and around the joints, which the body cannot repair. Currently there is no cure for arthritis, which significantly affects an individual's ability to manage daily activities, quality of life and productivity. Approximately 20% of women in Canada and 13% of men suffer from arthritis. Despite much effort, the causes and factors involved in the development of arthritis are not fully known. One form of growth factor called, transforming growth factor-beta (TGF-beta), which is produced in many tissues in the body is implicated in this disease process. Abnormal action of TGF-beta in the joints can potentially cause cartilage destruction leading to the development of osteoarthritis or other joint diseases. In the current research proposal, we plan to address and understand several unanswered questions related to the biology of TGF-beta in human cartilage cells (chondrocytes). Our goal will be to ascertain the causes for the abnormal action of TGF-beta in cartilage cells and what other factors in these cells take part in this process that ultimately leads to arthritic conditions. We believe that the knowledge gained from this proposed research may lead to the development of new therapeutic strategies for the treatment of this debilitating disease.
Program
Operating Grant
Location
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
332994
Name
Philip Anie
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Clinical Investigation - B: Arthritis, Bone, Skin and Cartilage
Projecttitle
Regulation of TGF-beta action in chondrocytes: signaling via ALK1 versus ALK5 pathways
Programtype2
Operating Grants
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Alk1; Animal Models; Cd109; Endoglin; Osteoarthritis; Tgf-Beta
Abstract
Arthritis commonly refers to several related conditions that affect joints, causing pain, inflammation and swelling and osteoarthritis is the most prevalent form. Osteoarthritis occurs when there is damage in and around the joints, which the body cannot repair. Currently there is no cure for arthritis, which significantly affects an individual's ability to manage daily activities, quality of life and productivity. Approximately 20% of women in Canada and 13% of men suffer from arthritis. Despite much effort, the causes and factors involved in the development of arthritis are not fully known. One form of growth factor called, transforming growth factor-beta (TGF-beta), which is produced in many tissues in the body is implicated in this disease process. Abnormal action of TGF-beta in the joints can potentially cause cartilage destruction leading to the development of osteoarthritis or other joint diseases. In the current research proposal, we plan to address and understand several unanswered questions related to the biology of TGF-beta in human cartilage cells (chondrocytes). Our goal will be to ascertain the causes for the abnormal action of TGF-beta in cartilage cells and what other factors in these cells take part in this process that ultimately leads to arthritic conditions. We believe that the knowledge gained from this proposed research may lead to the development of new therapeutic strategies for the treatment of this debilitating disease.
Competitiondate
201505
Approvedterm2
1 yr 0 mth
Pinamesdelim
Philip, Anie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~
Research Institute of the McGill University Health Ce… | Canada Spends